159 Solutions

159 Solutions is a life sciences analytics and consulting company focused on supporting biopharma clients with commercial analytics, business intelligence, visualization, and strategic decision support. The company has been described as providing advanced analytics, technology solutions, and contract research services to the life sciences industry, with particular strength in oncology, rare disease, and emerging biopharma use cases. In May 2018, 159 Solutions was acquired by IQVIA and now operates as part of IQVIA's Emerging BioPharma analytics organization. Rather than developing therapeutic products, the business helps pharma and biotech companies use healthcare data and analytical methods to improve commercialization, launch readiness, and portfolio decisions.